Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3515)
ANAPTYSBIO, INC (ANAB)
Marquet Magda — Director
Shares
1,710
Price
$48.85
Total Value
$83.53K
Shares Held After
9,930
% of Holdings
14.7%
ANAPTYSBIO, INC (ANAB)
Marquet Magda — Director
Shares
9,290
Price
$48.12
Total Value
$447.00K
Shares Held After
11,640
% of Holdings
44.4%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
12,563
Price
$5.10
Total Value
$64.07K
Shares Held After
650,298
% of Holdings
1.9%
Olema Pharmaceuticals, Inc. (OLMA)
Kovacs Shane William Charles — CH. OPERATING & FINANCIAL OFF.
Shares
100,000
Price
$28.73
Total Value
$2.87M
Shares Held After
139,727
% of Holdings
41.7%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
37,413
Price
$0.55
Total Value
$20.58K
Shares Held After
2,198,642
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
40
Price
$474.74
Total Value
$18.99K
Shares Held After
36,781
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,576
Price
$471.44
Total Value
$742.99K
Shares Held After
36,821
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
3,531
Price
$469.34
Total Value
$1.66M
Shares Held After
38,397
% of Holdings
8.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
407
Price
$472.28
Total Value
$192.22K
Shares Held After
41,928
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,307
Price
$470.37
Total Value
$614.77K
Shares Held After
42,335
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,439
Price
$468.32
Total Value
$673.92K
Shares Held After
43,642
% of Holdings
3.2%
Olema Pharmaceuticals, Inc. (OLMA)
Harmon Cyrus — Director
Shares
3,489
Price
$29.12
Total Value
$101.60K
Shares Held After
737,770
% of Holdings
0.5%
Scholar Rock Holding Corp (SRRK)
Qatanani Mo — CHIEF SCIENTIFIC OFFICER
Shares
13,112
Price
$45.20
Total Value
$592.61K
Shares Held After
108,964
% of Holdings
10.7%
Acrivon Therapeutics, Inc. (ACRV)
Blume-Jensen Peter — Director
Shares
49,000
Price
$1.68
Total Value
$82.12K
Shares Held After
2,095,771
% of Holdings
2.3%
Acrivon Therapeutics, Inc. (ACRV)
Levy Adam D. — Chief Financial Officer
Shares
8,832
Price
$1.70
Total Value
$15.00K
Shares Held After
20,983
% of Holdings
42.1%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
470
Price
$83.79
Total Value
$39.38K
Shares Held After
1,192,987
% of Holdings
0.0%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
5,386
Price
$83.16
Total Value
$447.90K
Shares Held After
1,193,457
% of Holdings
0.4%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
1,854
Price
$82.41
Total Value
$152.79K
Shares Held After
1,198,843
% of Holdings
0.2%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
2,374
Price
$81.00
Total Value
$192.29K
Shares Held After
1,200,697
% of Holdings
0.2%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
8,476
Price
$79.82
Total Value
$676.55K
Shares Held After
1,203,071
% of Holdings
0.7%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
1,440
Price
$78.64
Total Value
$113.24K
Shares Held After
1,211,547
% of Holdings
0.1%
ZIVO Bioscience, Inc. (ZIVO)
Maggiore Christopher D. — Director
Shares
1,766
Price
$8.49
Total Value
$14.99K
Shares Held After
519,292
% of Holdings
0.3%
ZIVO Bioscience, Inc. (ZIVO)
YALDOO LAITH L — Director
Shares
1,766
Price
$8.49
Total Value
$14.99K
Shares Held After
579,638
% of Holdings
0.3%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
19,621
Price
$5.12
Total Value
$100.46K
Shares Held After
662,861
% of Holdings
2.9%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
11,367
Price
$32.61
Total Value
$370.64K
Shares Held After
50,437
% of Holdings
18.4%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
30,616
Price
$0.57
Total Value
$17.45K
Shares Held After
2,236,055
% of Holdings
1.4%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
2,927
Price
$19.99
Total Value
$58.51K
Shares Held After
999,429
% of Holdings
0.3%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
2,596
Price
$19.99
Total Value
$51.89K
Shares Held After
885,014
% of Holdings
0.3%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
2,927
Price
$19.99
Total Value
$58.51K
Shares Held After
999,429
% of Holdings
0.3%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
2,596
Price
$19.99
Total Value
$51.89K
Shares Held After
885,014
% of Holdings
0.3%
Olema Pharmaceuticals, Inc. (OLMA)
Myles David C. — CH. DISCOV. & NON-CLIN DEV OFF
Shares
35,003
Price
$28.99
Total Value
$1.01M
Shares Held After
542,761
% of Holdings
6.1%
Olema Pharmaceuticals, Inc. (OLMA)
Myles David C. — CH. DISCOV. & NON-CLIN DEV OFF
Shares
14,997
Price
$28.60
Total Value
$428.91K
Shares Held After
577,764
% of Holdings
2.5%
Arcellx, Inc. (ACLX)
Heery Christopher — CHIEF MEDICAL OFFICER
Shares
5,882
Price
$68.51
Total Value
$403.00K
Shares Held After
23,749
% of Holdings
19.9%
Serina Therapeutics, Inc. (SER)
Moreadith Randall — Chief Scientific Officer
Shares
1,084
Price
$2.50
Total Value
$2.71K
Shares Held After
0
% of Holdings
100.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
26,105
Price
$4.89
Total Value
$127.65K
Shares Held After
682,482
% of Holdings
3.7%
Olema Pharmaceuticals, Inc. (OLMA)
Kovacs Shane William Charles — CH. OPERATING & FINANCIAL OFF.
Shares
3,822
Price
$28.01
Total Value
$107.05K
Shares Held After
239,727
% of Holdings
1.6%
Scholar Rock Holding Corp (SRRK)
Sinha Vikas — Chief Financial Officer
Shares
16,755
Price
$42.70
Total Value
$715.44K
Shares Held After
583,245
% of Holdings
2.8%
Scholar Rock Holding Corp (SRRK)
Woods Keith — Chief Operating Officer
Shares
16,746
Price
$42.70
Total Value
$715.05K
Shares Held After
583,254
% of Holdings
2.8%
Scholar Rock Holding Corp (SRRK)
Vaishnaw Akshay — Director
Shares
20,438
Price
$42.70
Total Value
$872.70K
Shares Held After
595,767
% of Holdings
3.3%
Scholar Rock Holding Corp (SRRK)
Hallal David — Director
Shares
57,450
Price
$42.70
Total Value
$2.45M
Shares Held After
1,541,645
% of Holdings
3.6%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
7,709
Price
$32.75
Total Value
$252.47K
Shares Held After
61,804
% of Holdings
11.1%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
43,198
Price
$0.55
Total Value
$23.76K
Shares Held After
2,266,671
% of Holdings
1.9%
Acrivon Therapeutics, Inc. (ACRV)
Devroe Eric — Chief Operating Officer
Shares
10,000
Price
$1.72
Total Value
$17.22K
Shares Held After
75,308
% of Holdings
13.3%
Apellis Pharmaceuticals, Inc. (APLS)
Chopas James George — VP/Chief Accounting Officer
Shares
873
Price
$22.19
Total Value
$19.37K
Shares Held After
52,595
% of Holdings
1.6%
Apellis Pharmaceuticals, Inc. (APLS)
DeLong Mark Jeffrey — Chief Business & Strat Officer
Shares
1,780
Price
$22.19
Total Value
$39.49K
Shares Held After
83,058
% of Holdings
2.1%
Apellis Pharmaceuticals, Inc. (APLS)
Deschatelets Pascal — Chief Scientific Officer
Shares
2,277
Price
$22.19
Total Value
$50.52K
Shares Held After
1,158,219
% of Holdings
0.2%
Apellis Pharmaceuticals, Inc. (APLS)
Francois Cedric — Director
Shares
10,186
Price
$22.19
Total Value
$226.00K
Shares Held After
321,419
% of Holdings
3.1%
Apellis Pharmaceuticals, Inc. (APLS)
Nicholson Nur — Chief Technical Officer
Shares
2,618
Price
$22.19
Total Value
$58.09K
Shares Held After
81,046
% of Holdings
3.1%
Apellis Pharmaceuticals, Inc. (APLS)
Sullivan Timothy Eugene — Chief Financial Officer
Shares
3,856
Price
$22.19
Total Value
$85.55K
Shares Held After
107,080
% of Holdings
3.5%
Apellis Pharmaceuticals, Inc. (APLS)
Watson David O. — General Counsel
Shares
5,780
Price
$22.19
Total Value
$128.24K
Shares Held After
98,838
% of Holdings
5.5%
Showing 2401–2450 of 3515 transactions (page 49 of 71)